Added to YB: 2026-01-12
Pitch date: 2026-01-02
LLY [bullish]
Eli Lilly and Company
-0.53%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
Market Cap
$952.3B
Pitch Price
$1.1K
Price Target
N/A
Dividend
0.65%
EV/EBITDA
34.03
P/E
52.03
EV/Sales
16.57
Sector
Pharmaceuticals
Category
growth
Show full summary:
50 Stocks for the New Year Pt 3 - Eli Lilly and Company
LLY: Dominates GLP-1 weight-loss market with superior pricing power vs competitors like Novo Nordisk. Revenue +54% YOY, massive R&D pipeline for future drugs. First healthcare co to hit $1T market cap (now $963B). Trades at 52x TTM P/E, 32x forward P/E.
Read full article (1 min)